GSK plc.
Market Reports 📊 93 Reports
76. Latest Development, Product Innovations and Treatments for Diabetes
The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.
77. Synthetic Biology: Global Markets
The global synthetic biology market should grow from $5.3 billion in 2019 to $18.9 billion by 2024 with a compound annual growth rate (CAGR) of 28.8% for the period of 2019-2024.
78. ROI in Pharmaceutical R&D: How to Halt the Decline
The global orphan drugs market should reach $315.6 billion by 2024 from $127.5 billion in 2017 at a compound annual growth rate (CAGR) of 13.8% for the forecast period of 2017 to 2024.
79. Global Dental Markets: Furniture, Equipment, Materials and Supplies
The global market for dental equipment, materials and supplies should grow from $60.5 billion in 2019 to reach $70.8 billion by 2024 at a compound annual growth rate (CAGR) of 3.2% for the period of 2
80. Pediatric Medicines: Global Markets
Get an overview of the global markets for pediatric medicines within the pharmaceutical industry. Analyses of the global market trends, with data from 2018, estimates for 2019, and projections of comp
81. Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies should grow from $346 billion in 2019 to $490 billion by 2024, at a compound annual growth rate (CAGR) of 7.2% fro
82. Electroceuticals: Technologies and Global Markets
The global market for electroceuticals should grow from $27.6 billion in 2019 to $39.2 billion by 2024 at a compound annual growth rate (CAGR) of 7.3% for the period of 2019-2024.
83. Communicable Disease Market: A BCC Research Overview
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate of 3.8% for the period of 2019-2024.
84. Neurology Market: A BCC Research Overview
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
85. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
86. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
87. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
88. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
89. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
90. Chronic Kidney Disease: Global Markets and Technologies Through 2023
According to BCC Research global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate of 3.8%.
91. Colorectal Cancer Therapeutics: Global Markets
The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate of 6.1% for the period 2018 to 2023.
92. Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate of 9.3% from 2018 to 2023.
93. Antihypertensives: Global Markets to 2023
The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.
